FDA Investigator Andrew O Ejiofor
Andrew O Ejiofor has conducted inspections on 2 sites in 1 countries as of 03 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
03 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Andrew O Ejiofor:
Alberto A Viciedo,
Annet R Rajan,
Brooke K Higgins,
Brooke K Seeman,
Carole L Jones,
Colleen F Hoyt,
Diane T Bargo,
Diane T O'brien,
Douglas C Kovacs,
Edmund F Mrak, Jr,
Edwin Melendez,
Emest F Bizjak,
Frederick F Razzaghi,
George M Ibrahim,
Helen Verdel,
Jonathan W Chapman,
Karen E D'orazio,
Keith M Reilly,
Kelli F Dobilas,
Laurissa S Flowers,
LCDR Anastasia M Piliafas Brown,
Li Li,
Lisa Harlan,
Lori S Lawless,
Marcellinus D Dordunoo,
Melba Trivera Clavell,
Melissa J Garcia,
Melissa T Roy,
Merideth K Rose,
Nerizza B Guerin,
Parul M Patel,
Patricia A Morrow,
Rachel C Harrington,
Rebecca Rodriguez,
Sharon K Thoma, PharmD,
Shirshendu K Deb, PhD,
Shusheen A Alexander,
Steven P Donald,
Suzanne M Healy,
Suzanne M Muchene,
Tajah L Blackburn,
Tara G Bizjak,
Vipulchandra N Dholakia,
William J Leonard
Andrew O Ejiofor's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2024 | FDA 483 | Bell-More Labs Inc - Form 483, 2024-04-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more